Skip to content

To explore the effects of O+O co-care mode and conventional care mode on glucose metabolism and maternal and infant outcomes of hyperglycemia patients during pregnancy

To explore the effects of O+O co-care mode and conventional care mode on glucose metabolism and maternal and infant outcomes of hyperglycemia patients during pregnancy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086688
Enrollment
Unknown
Registered
2024-07-09
Start date
2024-07-15
Completion date
Unknown
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperglycemia during pregnancy

Interventions

The co-care group:NA AI
Routine group:NA

Sponsors

Second Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Meet HIP diagnostic criteria; (2) Aged 20-45 years old; (3) Patients were treated with insulin

Exclusion criteria

Exclusion criteria: (1) Patients with systemic lupus erythematosus, anti-cardiolipin antibody syndrome and other autoimmune system diseases; (2) Patients with heart and lung function injury, liver and kidney function abnormality or other serious diseases; (3) Patients with serious mental illness and infectious diseases; (4) Patients with excessive alcohol or drug use; (5) Patients who had used drugs that may affect blood sugar, such as glucocorticoids, within 3 months before enrollment; (6) Patients who do not have access to the Internet or applications on their smartphones.

Design outcomes

Primary

MeasureTime frame
pregnancy outcome;

Secondary

MeasureTime frame
fasting blood-glucose;2-hour post-meal blood glucose;glycosylated hemoglobin;weight;

Countries

China

Contacts

Public ContactHe Yangfang

Second Hospital of Jilin University

ketuosahncao@163.com+86 138 4408 4450

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026